Ausgabe 2/2012
Inhalt (21 Artikel)
Immunotherapy for nonsmall-cell lung cancer
- short review
Astrid Belalcazar, Luis E. Raez, Edgardo S. Santos
Immunotherapeutic approaches targeting prostate cancer and its microenvironment
- short review
Robert Zeiser
Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders
- short review
Panagiotis D. Tsirigotis, Nikolaos Papanikolaou
The role of biomarkers in the choice of therapy in breast cancer
- short review
Brigitte Mlineritsch, Sigrun Ressler, Richard Greil
Evolving strategies to overcome endocrine resistance in breast cancer
- review
Michael Hubalek, Christine Brunner, Christian Marth
Surgical removal of the primary?—The role it plays in stage IV breast cancer
- short review
Florian Fitzal
The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer
- short review
Zoltán Lőcsei, Katalin Hideghéty, Zsuzsanna Kahán
Breast cancer: is there a need for biopsy of metastases?
- short review
Flora Zagouri, Martin Filipits
Advanced breast cancer: new imaging techniques for detection of metastases
- short review
Helmut Schoellnast, Christian Gstettner
Treatment outcome in AML: a single-centre experience in an unselected patient cohort
- original report
Kathrin Strasser-Weippl, Martin Schreder, Niklas Zojer, Heinz Ludwig
Sjögren syndrome complicated with hairy-cell leukemia: a case-based review
- case report
Noushin Bayat, Hasan Bagheri, Reza Karbasi-Afshar, Alireza Saadat, Farhad Sarrafzadeh, Amin Saburi
Lung cancer screening: current evidence and recommendations
- short review
Michael Mark, Martin Brutsche, Oliver Gautschi
Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?
- case report
Ulf Petrausch, Verena Tischler, Walter Weder, Rolf Stahel, Alex Soltermann
Recent advances and future challenges in the treatment of upper gastrointestinal malignancies
- short review
Dieter Koeberle, Anna Dorothea Wagner
Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)
- comment
Markus Peck-Radosavljevic
Highlights in the adjuvant treatment of colon cancer from annual meetings 2011
- short review
Gudrun Resch, Josef Thaler
